In one paragraphArticle in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Hassan KawtharanyDepartment of Internal Medicine, Evidence-Based Practice and Impact Center, University of Kansas Medical Center, Kansas City, KS.ORCID 0009-0007-3725-8485 Muayad AzzamDepartment of Internal Medicine, Evidence-Based Practice and Impact Center, University of Kansas Medical Center, Kansas City, KS.ORCID 0000-0002-2046-8343 Jana KhawandiDepartment of Internal Medicine, Evidence-Based Practice and Impact Center, University of Kansas Medical Center, Kansas City, KS.ORCID 0000-0001-7581-4787 Qais HamarshaDepartment of Internal Medicine, Evidence-Based Practice and Impact Center, University of Kansas Medical Center, Kansas City, KS.ORCID 0000-0001-9711-4650 Ali ChoaibDepartment of Internal Medicine, Evidence-Based Practice and Impact Center, University of Kansas Medical Center, Kansas City, KS.ORCID 0009-0005-3132-394X Aseel AlkhaderDepartment of Internal Medicine, Evidence-Based Practice and Impact Center, University of Kansas Medical Center, Kansas City, KS.
Jamil NazzalDepartment of Internal Medicine, Evidence-Based Practice and Impact Center, University of Kansas Medical Center, Kansas City, KS.
Hadeel AlkasrawiKing Hussien Cancer Center, Amman, Jordan.
Omar KhanfarDepartment of Pediatric Infectious Disease, Vanderbilt University Medical Center, Nashville, TN.
Riten KumarDepartment of Pediatrics, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.ORCID 0000-0001-8004-4190 Sarah E SartainSection of Hematology, Department of Pediatrics, Baylor College of Medicine/Texas Children's Hospital, Houston, TX.ORCID 0000-0003-2204-4568 Marisol BetenskyJohns Hopkins All Children's Hospital, St. Petersburg, FL.
Paul MonagleRoyal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, VIC, Australia.ORCID 0000-0002-3970-8984 Reem A MustafaDepartment of Internal Medicine, Evidence-Based Practice and Impact Center, University of Kansas Medical Center, Kansas City, KS.ORCID 0000-0002-2091-0875 ASH/ISTH VTE Prophylaxis Pediatrics Guideline Group
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID42349022
PMCPMC13546890
What OpenQuestion holds
Textmetadata
Read underepoch 390